Drug Safety

The US FDA `Black Box' Warning for Topical Calcineurin Inhibitors: An Ongoing Controversy
pp. 185-198(14)
Authors: Ring, Johannes; Möhrenschlager, Matthias; Henkel, Verena

Drug-Induced Taste Disorders
pp. 199-215(17)
Authors: Doty, Richard L.; Shah, Muhammad; Bromley, Steven M.

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 1: In Major Surgery
pp. 217-230(14)
Authors: Fraser, Ian S.; Porte, Robert J.; Kouides, Peter A.; Lukes, Andrea S.

Frequency and Clinical Relevance of Drug Interactions with Lovastatin and Simvastatin: An Observational Database Study
pp. 231-240(10)
Authors: Tirkkonen, Tuire; Ryynänen, Anna; Vahlberg, Tero; Irjala, Kerttu; Klaukka, Timo; Huupponen, Risto; Laine, Kari

Post-Marketing Surveillance of Ischaemic Optic Neuropathy in Male Veterans Co-Prescribed Phosphodiesterase-5 Inhibitors with Organic Nitrates or α-Blockers
pp. 241-247(7)
Authors: French, Dustin D.; Margo, Curtis E.

Improving the Detection of Subtle IKr-Inhibition: Assessing Electrocardiographic Abnormalities of Repolarization Induced by Moxifloxacin
pp. 249-260(12)
Authors: Couderc, Jean-Philippe; McNitt, Scott; Hyrien, Ollivier; Vaglio, Martino; Xia, Xiajuan; Polonsky, Slava; Moss, Arthur J.; Zareba, Wojciech

Use of Over-the-Counter Analgesics in Patients with Chronic Liver Disease: Physicians' Recommendations
pp. 261-270(10)
Authors: Rossi, Simona; Assis, David N.; Awsare, Monica; Brunner, Mark; Skole, Kevin; Rai, Jitha; Andrel, Jocelyn; Herrine, Steven K.; Reddy, Rajender K.; Navarro, Victor J.

The `Power' of Signal-Detection Algorithms
pp. 271-272(2)
Authors: Karim, M. Rezaul; Klincewicz, Stephen L.; Yee, Chuen L.

The Authors' Reply
pp. 272-273(2)
Authors: Matsushita, Yasuyuki; Kuroda, Yasufumi; Niwa, Shinpei; Sonehara, Satoshi; Hamada, Chikuma; Yoshimura, Isao